177 related articles for article (PubMed ID: 22248821)
21. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
Ruan Y; Liu W; Xu X; Weng SQ; Shao SK; Zhou WQ; Teng Z; Gu HX; Zhu ZY; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):274-6. PubMed ID: 11986705
[TBL] [Abstract][Full Text] [Related]
22. Immunization effect of purified bivalent vaccine to haemorrhagic fever with renal syndrome manufactured from primary cultured hamster kidney cells.
Dong GM; Han L; An Q; Liu WX; Kong Y; Yang LH
Chin Med J (Engl); 2005 May; 118(9):766-8. PubMed ID: 15899141
[No Abstract] [Full Text] [Related]
23. Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies.
Higa MM; Petersen J; Hooper J; Doms RW
Virology; 2012 Feb; 423(2):134-42. PubMed ID: 22209230
[TBL] [Abstract][Full Text] [Related]
24. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
[TBL] [Abstract][Full Text] [Related]
25. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization.
Xu Z; Wei L; Wang L; Wang H; Jiang S
Biochem Biophys Res Commun; 2002 Nov; 298(4):552-8. PubMed ID: 12408987
[TBL] [Abstract][Full Text] [Related]
26. Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle.
Ying Q; Ma T; Cheng L; Zhang X; Truax AD; Ma R; Liu Z; Lei Y; Zhang L; Ye W; Zhang F; Xu Z; Shang L; Liu R; Wang F; Wu X
Oncotarget; 2016 Sep; 7(39):63488-63503. PubMed ID: 27542281
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine.
McClain DJ; Summers PL; Harrison SA; Schmaljohn AL; Schmaljohn CS
J Med Virol; 2000 Jan; 60(1):77-85. PubMed ID: 10568767
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial.
Beckett CG; Tjaden J; Burgess T; Danko JR; Tamminga C; Simmons M; Wu SJ; Sun P; Kochel T; Raviprakash K; Hayes CG; Porter KR
Vaccine; 2011 Jan; 29(5):960-8. PubMed ID: 21111785
[TBL] [Abstract][Full Text] [Related]
30. Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7.
Li K; Li PY; Wu XA; Zhang L; Liu ZY; Yu L; Zhang L; Cheng LF; Bai WT; Zhang FL; Xu ZK
Int J Mol Med; 2013 Sep; 32(3):709-16. PubMed ID: 23783439
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus.
Spik K; Shurtleff A; McElroy AK; Guttieri MC; Hooper JW; SchmalJohn C
Vaccine; 2006 May; 24(21):4657-66. PubMed ID: 16174542
[TBL] [Abstract][Full Text] [Related]
32. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
[TBL] [Abstract][Full Text] [Related]
33. Cellular immune response to Hantaan virus nucleocapsid protein in the acute phase of hemorrhagic fever with renal syndrome: correlation with disease severity.
Wang M; Wang J; Zhu Y; Xu Z; Yang K; Yang A; Jin B
J Infect Dis; 2009 Jan; 199(2):188-95. PubMed ID: 19072554
[TBL] [Abstract][Full Text] [Related]
34. Genetic and antigenic analyses of a Puumala virus isolate as a potential vaccine strain.
Abu Daude NH; Kariwa H; Tkachenko E; Dzagurnova T; Medvedkina O; Tkachenko P; Ishizuka M; Seto T; Miyashita D; Sanada T; Nakauchi M; Yoshii K; Maeda A; Yoshimatsu K; Arikawa J; Takashima I
Jpn J Vet Res; 2008 Nov; 56(3):151-65. PubMed ID: 19177744
[TBL] [Abstract][Full Text] [Related]
35. [Detection of anti-hantavirus antibodies in forest workers in the north-east of Poland].
Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Swierzbińska R; Moniuszko A; Pawlak-Zalewska W
Przegl Epidemiol; 2008; 62(3):531-7. PubMed ID: 19108515
[TBL] [Abstract][Full Text] [Related]
36. Fusion with extracellular domain of cytotoxic T-lymphocyte-associated-antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice.
Liu F; Liang M; Cao S; Liu Q; Zhang Q; Li C; Zhang S; Wang S; Li D
Virol J; 2011 Sep; 8():448. PubMed ID: 21943202
[TBL] [Abstract][Full Text] [Related]
37. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.
Hooper JW; Custer DM; Smith J; Wahl-Jensen V
Virology; 2006 Mar; 347(1):208-16. PubMed ID: 16378630
[TBL] [Abstract][Full Text] [Related]
38. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus.
Liang M; Chu YK; Schmaljohn C
Virology; 1996 Mar; 217(1):262-71. PubMed ID: 8599211
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of subclinical infection rates between vaccinated group with type I inactivated vaccine against hemorrhagic fever and controls].
Ruan Y; Xu X; Shao S; Tong Z; Weng S; Zhou W; Gu H; Zhu Z; Xu Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):308-10. PubMed ID: 11864500
[TBL] [Abstract][Full Text] [Related]
40. [Safety and immunogenicity of inactivated bivalent EHF vaccine in humans].
Liu W; Xu X; Ruan Y; Weng S; Liu W; Zhou W; Dong G; Gu H; Zhu Z; Xu Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):445-7. PubMed ID: 11860832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
